Stay updated on Satralizumab in Generalized Myasthenia Gravis Clinical Trial
Sign up to get notified when there's something new on the Satralizumab in Generalized Myasthenia Gravis Clinical Trial page.

Latest updates to the Satralizumab in Generalized Myasthenia Gravis Clinical Trial page
- Check2 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe Italy location entry was updated from Napoli, Campania, 80131 to Naples, Campania, 80131. The page revision label changed from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check45 days agoChange DetectedRevision: v3.4.3 is now displayed, replacing Revision: v3.4.2. This appears to be a small administrative update with no changes to study details.SummaryDifference0.0%

- Check52 days agoChange DetectedResults have been posted for the study and the status updated to Terminated; the page now reflects the published outcomes.SummaryDifference0.0%

- Check67 days agoChange DetectedAdded Revision: v3.4.2 and removed Revision: v3.4.1 on the page.SummaryDifference0.0%

- Check74 days agoChange DetectedRevision: v3.4.1 was added and v3.4.0 was removed; this appears to be an administrative update with no visible impact on the study content or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Satralizumab in Generalized Myasthenia Gravis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Satralizumab in Generalized Myasthenia Gravis Clinical Trial page.